Satoshi Ota

5.4k total citations
147 papers, 4.0k citations indexed

About

Satoshi Ota is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Satoshi Ota has authored 147 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 39 papers in Pulmonary and Respiratory Medicine and 30 papers in Surgery. Recurrent topics in Satoshi Ota's work include Venous Thromboembolism Diagnosis and Management (23 papers), CRISPR and Genetic Engineering (10 papers) and Medical Imaging and Pathology Studies (10 papers). Satoshi Ota is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), CRISPR and Genetic Engineering (10 papers) and Medical Imaging and Pathology Studies (10 papers). Satoshi Ota collaborates with scholars based in Japan, United States and China. Satoshi Ota's co-authors include Atsuo Kawahara, Yu Hisano, Masashi Fukayama, Norikazu Yamada, Masaaki Ito, Hamid Band, Mashio Nakamura, Mark Lupher, Ken Ishikura and Hiroyuki Aburatani and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Satoshi Ota

143 papers receiving 3.9k citations

Peers

Satoshi Ota
Thomas Schwarz Germany
Harald Schulze Germany
Calvin Vary United States
Pieter A. van der Velden Netherlands
Najet Debili France
Frans A. Prins Netherlands
Leon W. Hoyer United States
C. R. M. Hay United Kingdom
Michaëla Fontenay France
Michael Brown United States
Thomas Schwarz Germany
Satoshi Ota
Citations per year, relative to Satoshi Ota Satoshi Ota (= 1×) peers Thomas Schwarz

Countries citing papers authored by Satoshi Ota

Since Specialization
Citations

This map shows the geographic impact of Satoshi Ota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Ota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Ota more than expected).

Fields of papers citing papers by Satoshi Ota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Ota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Ota. The network helps show where Satoshi Ota may publish in the future.

Co-authorship network of co-authors of Satoshi Ota

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Ota. A scholar is included among the top collaborators of Satoshi Ota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Ota. Satoshi Ota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Rikiya, Takayuki Ishige, Takafumi Sangai, et al.. (2023). The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant therapy for postmenopausal luminal breast cancer patients. BMC Cancer. 23(1). 384–384. 3 indexed citations
2.
Inoue, Hiromichi, Jun Matsushima, Satoru Kobayashi, et al.. (2021). Expression of SATB2 in Neuroendocrine Carcinomas of the Lung: Frequent Immunopositivity of Large Cell Neuroendocrine Carcinoma with a Diagnostic Pitfall. International Journal of Surgical Pathology. 30(2). 151–159. 1 indexed citations
3.
Hayashi, Gosuke, Hiroki Ueda, Satoshi Ota, et al.. (2021). Base-resolution analysis of 5-hydroxymethylcytidine by selective oxidation and reverse transcription arrest. Organic & Biomolecular Chemistry. 19(29). 6478–6486. 2 indexed citations
4.
Kano, Masayuki, Koichi Hayano, Hideki Hayashi, et al.. (2019). Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis. Annals of Surgical Oncology. 26(6). 1805–1813. 27 indexed citations
5.
Muto, Tomoya, Naoya Mimura, Shokichi Tsukamoto, et al.. (2018). Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma. International Journal of Hematology. 108(4). 452–455. 2 indexed citations
6.
Mikata, Rintaro, Takashi Kishimoto, Masahiro Hayashi, et al.. (2017). Immunohistochemical analysis of IMP3 and p53 expression in endoscopic ultrasound-guided fine needle aspiration and resected specimens of pancreatic diseases. Pancreatology. 18(2). 176–183. 22 indexed citations
7.
8.
Morimoto, Junichi, Takahiro Nakajima, Hidemi Suzuki, et al.. (2016). Impact of free tumor clusters on prognosis after resection of pulmonary adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 152(1). 64–72.e1. 81 indexed citations
9.
Yamanouchi, Dai, Toshiyuki Oshitari, Yosuke Nakamura, et al.. (2013). Primary Neuroendocrine Carcinoma of Ocular Adnexa. SHILAP Revista de lepidopterología. 2013. 1–4. 8 indexed citations
10.
Kagoya, Yuki, Tsuyoshi Takahashi, Yasuhito Nannya, et al.. (2011). Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases. Clinical Transplantation. 25(5). E552–7. 2 indexed citations
11.
Maeda, Daichi, Satoshi Ota, Yutaka Takazawa, et al.. (2010). Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 457(5). 597–608. 20 indexed citations
12.
Ushiku, Tetsuo, Hiroshi Uozaki, Aya Shinozaki‐Ushiku, et al.. (2009). Glypican 3‐expressing gastric carcinoma: Distinct subgroup unifying hepatoid, clear‐cell, and α‐fetoprotein‐producing gastric carcinomas. Cancer Science. 100(4). 626–632. 72 indexed citations
13.
Maeda, Daichi, Satoshi Ota, Yutaka Takazawa, et al.. (2009). Glypican-3 expression in clear cell adenocarcinoma of the ovary. Modern Pathology. 22(6). 824–832. 90 indexed citations
14.
Kusakabe, Masashi, Kousuke Watanabe, Hidenori Kage, et al.. (2009). Identification of G0S2 as a gene frequently methylated in squamous lung cancer by combination of in silico and experimental approaches. International Journal of Cancer. 126(8). 1895–1902. 46 indexed citations
15.
Ota, Satoshi, Noriko Tonou‐Fujimori, & Kyo Yamasu. (2008). The roles of the FGF signal in zebrafish embryos analyzed using constitutive activation and dominant-negative suppression of different FGF receptors. Mechanisms of Development. 126(1-2). 1–17. 33 indexed citations
16.
Inoue, Fumitaka, Satoshi Ota, Md. Ekramul Islam, et al.. (2006). Genomic organization, alternative splicing, and multiple regulatory regions of the zebrafishfgf8gene. Development Growth & Differentiation. 48(7). 447–462. 24 indexed citations
17.
Yoshida, Takayuki, Toshiyuki Harada, Satoshi Fuke, et al.. (2004). Lung Adenocarcinoma Presenting With Enlarged and Multiloculated Cystic Lesions Over 2 Years. Respiratory Care. 49(12). 1522–1524. 22 indexed citations
18.
Ota, Satoshi, Hideki Kataoka, Masao Kanamori, et al.. (2002). Negative regulation of EphA2 receptor by Cbl. Biochemical and Biophysical Research Communications. 296(1). 214–220. 56 indexed citations
19.
Rao, Navin, Mark Lupher, Satoshi Ota, et al.. (2000). The Linker Phosphorylation Site Tyr292 Mediates the Negative Regulatory Effect of Cbl on ZAP-70 in T Cells. The Journal of Immunology. 164(9). 4616–4626. 90 indexed citations
20.
Ota, Satoshi, Kaoru Hazeki, Navin Rao, et al.. (2000). The RING Finger Domain of Cbl Is Essential for Negative Regulation of the Syk Tyrosine Kinase. Journal of Biological Chemistry. 275(1). 414–422. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Schwarz Breakdown of academic impact, for papers by Harald Schulze Breakdown of academic impact, for papers by Calvin Vary Breakdown of academic impact, for papers by Pieter A. van der Velden Breakdown of academic impact, for papers by Najet Debili Breakdown of academic impact, for papers by Frans A. Prins Breakdown of academic impact, for papers by Leon W. Hoyer Breakdown of academic impact, for papers by C. R. M. Hay Breakdown of academic impact, for papers by Michaëla Fontenay Breakdown of academic impact, for papers by Michael Brown
Rankless by CCL
2026